Overview
The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.
Eligibility
Inclusion Criteria:
- Patient > 18 years old
- Breast cancer patient candidate for adjuvant hormone therapy
- Mastery of the French language
- Patient with a cell phone and an Internet connection
- Patient able to use a computer, smartphone, or tablet.
- Patient affiliated to a social security system
- Signing of informed consent prior to any specific study-related procedure
Exclusion Criteria:
- Patient who has previously received hormone therapy for cancer.
- Patient not trained in the use of the application
- Any associated medical or psychiatric condition that might compromise the patient's ability to participate in the study
- Patients with locoregional or metastatic recurrence
- Other history of cancer.
- Patient deprived of liberty, under guardianship or curatorship
- Simultaneous participation in a therapeutic clinical trial or other clinical study involving a connected tool
- Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons